Literature DB >> 34541152

Advanced Design of Minimalistic Dumbbell-shaped Gene Expression Vectors.

Xiaoou Jiang1, Volker Patzel1.   

Abstract

Minimal DNA vectors exclusively comprising therapeutically relevant sequences hold great promise for the development of novel therapeutic regimen. Dumbbell-shaped vectors represent non-viral non-integrating DNA minimal vectors which have entered an advanced stage of clinical development ( Hardee et al., 2017 ). Spliceable introns and DNA nuclear import signals such as SV40 enhancer sequences are molecular features that have found multiple applications in plasmid vectors to improve transgene expression. In dumbbells however, effects triggered by introns were not investigated and DNA-based nuclear import sequences have not found applications yet, presumably because dumbbell vectors have continuously been minimized with regard to size. We investigated the effects of an intron and/or SV40 enhancer derived sequences on dumbbell vector driven reporter gene expression. The implementation of a spliceable intron was found to enhance gene expression unconditionally in all investigated cell lines. Conversely, the use of the SV40 enhancer improved gene expression in a cell type-dependent manner. Though both features significantly enlarge dumbbell vector size, neither the intron nor the enhancer or a combination of both revealed a negative effect on gene expression. On the contrary, both features together improved dumbbell-driven gene expression up to 160- or 56-fold compared with plasmids or control dumbbells. Thus, it is highly recommended to consider an intron and the SV40 enhancer for dumbbell vector design. Such an advanced design can facilitate pre-clinical and clinical applications of dumbbell-shaped DNA vectors.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Dumbbell vector; Genetic therapy; Intron; Minimal DNA vector; SV40 enhancer; Transgene expression

Year:  2017        PMID: 34541152      PMCID: PMC8413635          DOI: 10.21769/BioProtoc.2425

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  8 in total

1.  Sequence requirements for plasmid nuclear import.

Authors:  D A Dean; B S Dean; S Muller; L C Smith
Journal:  Exp Cell Res       Date:  1999-12-15       Impact factor: 3.905

2.  Splicing is required for rapid and efficient mRNA export in metazoans.

Authors:  M J Luo; R Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide.

Authors:  R Schirmbeck; S A König-Merediz; P Riedl; M Kwissa; F Sack; M Schroff; C Junghans; J Reimann; B Wittig
Journal:  J Mol Med (Berl)       Date:  2001-06       Impact factor: 4.599

4.  Enzymatic ligation assisted by nucleases: simultaneous ligation and digestion promote the ordered assembly of DNA.

Authors:  Gregory J Cost
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

5.  Advanced Design of Dumbbell-shaped Genetic Minimal Vectors Improves Non-coding and Coding RNA Expression.

Authors:  Xiaoou Jiang; Han Yu; Cui Rong Teo; Genim Siu Xian Tan; Sok Chin Goh; Parasvi Patel; Yiqiang Kevin Chua; Nasirah Banu Sahul Hameed; Antonio Bertoletti; Volker Patzel
Journal:  Mol Ther       Date:  2016-06-30       Impact factor: 11.454

6.  Import of plasmid DNA into the nucleus is sequence specific.

Authors:  D A Dean
Journal:  Exp Cell Res       Date:  1997-02-01       Impact factor: 3.905

7.  Bacteriophage T7 DNA replication. Synthesis of lagging strands in a reconstituted system using purified proteins.

Authors:  M J Engler; C C Richardson
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

8.  Advances in Non-Viral DNA Vectors for Gene Therapy.

Authors:  Cinnamon L Hardee; Lirio Milenka Arévalo-Soliz; Benjamin D Hornstein; Lynn Zechiedrich
Journal:  Genes (Basel)       Date:  2017-02-10       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.